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Abstract
Background While respiratory muscle strength is recognized to decline with aging process, the relationship between
sarcopenia and pulmonary function remains to be studied. The present study was undertaken to provide a better insight into
the comprehension of the relationship between pulmonary function and muscle function (strength and physical performance)
using an unselected sample of subjects assessed during the Longevity Check-up 7+ project.
Methods Look-up 7+ is an ongoing cross-sectional survey started in June 2015 and conducted in unconventional settings (i.e.
exhibitions, malls, and health promotion campaigns) across Italy. Candidate participants are eligible for enrolment if they are
at least 18 years of age and provide written informed consent. Muscle strength was assessed by handgrip strength test, and
physical performance was evaluated by chair stand test. Spirometer analysis was performed using the AirSmart system, and
the largest forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and peak expiratory flow (PEF) values were
collected.
Results The mean age of 925 subjects participating in the Longevity check-7+ surveys and receiving the spirometer evaluation
was 55.6 years (range from 18 to 98 years), and 501 (54%) were women. Overall, both in male and female participants,
FVC, FEV1 and PEF positively correlated with handgrip strength and chair stand tests. The receiver operator characteristic
curve analysis revealed that the areas under the curves for FVC, FEV1, and PEF were 0.79, 0.80 and 0.80, respectively.
Conclusions The results clearly show that pulmonary function was positively associated with handgrip strength and chair
stand tests. Based on this observation, muscle strength, physical performance, and pulmonary function should be recom-
mended as the method of choice for the early detection of individuals at risk of probable sarcopenia and at the same time
to better characterized the severity of sarcopenia status.
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Introduction
Advancing age is linked with important changes in body
composition, the most remarkable of which, sarcopenia, is a
major cause of physical function decline, disability, and
mortality.1,2 Some studies have assessed the changes in
muscle function during the aging process documenting a
substantial age-related decline in both muscle mass and
physical performance.3–5 In general, muscle strength (as
measured by handgrip test) and physical performance
(as measured by chair stand test) were both stable in the first
decades of adulthood and start to decrement in the middle
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years (45+) and late adulthood. In particular, individuals with
more than 75 years lose >30% in muscle strength and
physical function.6
Similarly, maximal inspiratory and expiratory muscle
strength is recognized to decline with advancing age,7,8 and
this age-related reduction in respiratory function is correlated
to sarcopenia of the respiratory muscle.9 In particular,
pulmonary functions, such as the forced vital capacity (FVC),
the forced expiratory volume in 1 s (FEV1), and the peak
expiratory flow rate (PEF), decrease with aging due to
modifications in elastic recoil and thorax compliance.10,11
Previous studies described that reduced muscle function
was correlated with decreased pulmonary function in
subjects with lung disease, such as chronic obstructive pul-
monary disease.12–14 Recently, Bahat et al.15 demonstrated
that muscle strength, assessed by handgrip strength, was
positively associated with maximal inspiratory and expiratory
muscle strength. However, there is little evidence about how
muscle strength and physical performance are connected to
pulmonary function in asymptomatic subjects without a clear
diagnosis of pulmonary disease.
The present study was, therefore, undertaken to provide a
better insight into the comprehension of the relationship be-
tween pulmonary function and muscle function (strength and
physical performance) using an unselected sample of subjects
assessed during the Longevity Check-up 7+ project.
Materials and methods
We used data from the Longevity Check-up 7+ (Look-up 7+)
study, an initiative developed by the Geriatric Medicine De-
partment of Catholic University of Rome and specifically de-
signed with the aim of encouraging a healthy lifestyle in the
general population. Subjects visiting public environments
(i.e. exhibition and shopping centre) or subjects adhering to
prevention campaigns have been screened using a specific
questionnaire on lifestyle and performed a brief check-up.
The Look-up 7+ study protocol has been described in detail
elsewhere.6,16 Participants were designated as eligible for the
check-up if they were at least 18 years of age and provided
written informed consent. Exclusion criteria were self-
reported pregnancy, an inability to complete the physical
performance test, refusal of the blood capillary check, or an
inability to give written informed consent. Within the context
of the National Campaigns for cardiovascular prevention,16
the Catholic University of Sacred Heart Ethical Committee
ratified the study protocol.
Study Sample
Between 1 June 2015 and 30 November 2018, we enrolled
10 644 individuals in different surveys and Italian
cities adhering the national campaign, named “Longevity
Check-up 7+” (Look-up 7+) and promoted by the Catholic
University of Rome. For the present study, 925 subjects who
performed the spirometer assessment were included.
Data collection
All people who accepted to be screened underwent individual
assessments consisting of a brief questionnaire, the measure-
ment of objective cardiovascular health metrics, and the
evaluation of anthropometric parameters (height and weight)
and functional performance (lower extremity muscle power).
In particular, the Look-up 7+ visit is structured to collect the
following information and data: informed consent, lifestyle in-
terview (smoking, eating habits, physical activity, and previous
screening performed), blood pressure measurement, weight
and height (body mass index calculation) assessment, and cho-
lesterol and glucose measurements.16,17
Smoking habit was categorized as current or never/former
smoker. Body weight was measured through an analogue
medical scale. Body height was measured using a standard
stadiometer. BMI was defined as weight (kg) divided by the
square of height (m). Healthy diet was considered as the
consumption of at least three portions of fruit and/or
vegetables per day.18 Regular participation in physical activity
was considered as involvement in exercise training at least
twice a week. Cholesterol was measured from capillary
blood samples using changing reagent strips based on
a reflectometric system with the portable device
MultiCare-In.19 Random blood glucose was measured from
capillary blood samples using changing reagent strips based
on an amperometric system with the portable device
MultiCare-In.19 Blood pressure was measured with an
electronic sphygmomanometer according to recommenda-
tions from international guidelines.20
Muscle strength and physical performance
assessment
Muscle strength was assessed by handgrip strength test,
which was measured by using a dynamometer (North Coast
Hydraulic Hand Dynamometer; North Coast Medical, Inc,
Morgan Hill, CA). Participants performed one familiarization
trial and one measurement trial with each hand,
and the result from the stronger side was used for the
analyses.
During the Look-up 7+ screening visit, participants’ physical
performances were evaluated by chair stand test. Subjects
were asked to stand up from a chair with their arms folded
across the chest five times in a row as quickly as possible. A
standard armless chair is used, usually 43–47 cm in height.
The back of the chair is stabilized against a wall to ensure
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safety and stability. The time taken to perform the task is
measured using a handheld stopwatch; increased time re-
flects poorer performance. The five-repetition chair stand test
is simple to use, reliable, and valid measure of physical
function in adult and older people, including those with mus-
culoskeletal or neurological conditions. Poor performance on
this test highlights mobility problems and is associated with
subsequent disability.21
Pulmonary function assessment
Because of the cost and the time to be performed, the spi-
rometer assessment was randomly performed in a subsample
of Look-up 7+ project participants.
Spirometer analysis was performed according to recom-
mendations from the American Thoracic Society guidelines.22
Measurements were made using the AirSmart system
(https://www.nuvoair.com/). Participants were seated com-
fortably in a chair using a nose clip. Each subject completed
tests three times with satisfactory curves; the largest FVC,
FEV1, and PEF values were collected. Participants were asked
to inhale to the point of maximal inspiration and exhale as
quickly as possibly over the following 6 s. Effort during
measurement was evaluated using a flow-volume curve.
Statistical analyses
Continuous variables were expressed as mean ± standard
deviation (SD), and categorical variables as frequencies by
absolute value and percentage (%) of the total. Descriptive
statistics were used to describe demographic and key clinical
characteristics of the study population according to gender.
The differences in proportions and the means of covariates
between the genders were assessed using Fisher’s exact test
and t-test statistics, respectively.
The correlation between the pulmonary parameters and
physical performance tests was calculated using Pearson’s
correlation, and the limits of agreement between measures
were assessed by Blant–Altman plots. Graph insets indicate
Pearson’s r correlation values and P bilateral significance
values (r and P, respectively). Additionally, to explore the
power of FVC, FEV1, and PEF for predicting sarcopenia status,
receiver operator characteristic (ROC) curves were plotted,
and the area under the curve (AUC) reported, along with
sensitivity and specificity at the threshold that maximized
the sum of sensitivity and specificity (Youden’s index).
All analyses were performed using SPSS software (version
11.0, SPSS Inc., Chicago, IL).
Results
The mean age of 925 subjects participating in the Longevity
check-7+ surveys and receiving the spirometer evaluation
was 55.6 years (standard deviation 14, range from 18 to
98 years), and 501 (54%) were women. Characteristics of
the study population according to the physical activity are
summarized in Table 1. As compared with male
participants, female had a higher prevalence of normal body
mass index and normal blood pressure (P < 0.001). On the
contrary, female participants showed a higher prevalence of
smoking habits (22% vs. 14%, respectively; P < 0.01). Male
participants were more involved in physical activity compared
Table 1 Characteristics of study population according to gender
Characteristics Total sample (n = 925) Male (n = 424) Female (n = 501) P
General and clinical characteristics
Age (years) 55.6 ± 14.0 56.5 ± 13.9 55.3 ± 14.1 0.46
No smoking 754 (82) 362 (86) 392 (78) <0.01
Healthy diet 594 (66) 263 (63) 331 (68) 0.09
Physically active 529 (57) 258 (61) 271 (54) 0.03
Normal BMI (<25 kg/m2) 483 (52) 184 (43) 299 (59) <0.001
No hypertension 497 (51) 186 (44) 281 (56) <0.001
No dyslipidaemia 293 (33) 121 (29) 172 (35) 0.08




7.8 ± 2.2 7.7 ± 2.1 7.8 ± 2.2 0.36
Handgrip (kg) 32.1 ± 11.4 41.8 ± 8.8 24.2 ± 5.8 <0.001
Lung function measurements
FVC (L) 4.0 ± 1.2 4.8 ± 1.0 3.3 ± 0.8 <0.001
FEV1 (L) 3.0 ± 0.9 3.6 ± 0.8 2.5 ± 0.6 <0.001
FEV1/FVC (%) 75.3 ± 7.5 75.2 ± 7.5 75.4 ± 7.5 0.77
PEF (L/s) 6.5 ± 2.5 8.1 ± 2.5 5.2 ± 1.6 <0.001
BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEF, peak expiratory flow.
Data are given as number (per cent) for smoking, healthy diet, physical activity, normal BMI, hypertension, dyslipidaemia, diabetes; for all
the other variables, means ± SD are reported. Healthy diet: consumption of at least three portions of fruit and/or vegetables per day. Phys-
ically active: physical exercise at least twice a week. No dyslipidaemia: serum cholesterol level of <200 mg/dL.
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with female subjects (P = 0.03). As expected, male showed a
significant higher handgrip strength and better respiratory
performance than female subjects. No difference was
observed for the chair stand test.
Pearson’s correlation coefficients were calculated to
determine the correlation between spirometer parameters
and physical performance tests. Figure 1 shows the correlation
between pulmonary function and chair stand test in male par-
ticipants (Panels A, B, and C) and female participants (Panels D,
E, and F). Overall, both in male and female participants, FVC,
FEV1, and PEF positively correlated with chair stand test. Bet-
ter results in pulmonary parameters correspond better perfor-
mance in chair stand test. Similarly, FVC, FEV1, and PEF
positively correlated with handgrip strength test (Figure 2,
Panels A, B, and C for male participants and Panels D, E, and
F for female participants).
The ROC curve analysis revealed that the AUCs for FVC,
FEV1, and PEF were 0.79, 0.80, and 0.80, respectively
(Figure 3). The optimal cut-off value in male of FVC was
3.60 L, and the sensitivity and specificity were 88% and
Figure 1 The correlation between pulmonary function and chair stand tests in male participants (Panels A, B, and C) and female participants (Panels D,
E, and F). FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEF, peak expiratory flow.
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60%, respectively. For FEV1, the optimal cut-off value was
2.60 L, and the sensitivity and specificity were 89% and
45%, respectively. For PEF, the optimum cut-off value was
4.90 L, and the sensitivity and specificity were 91% and
55%, respectively. The optimal cut-off value in female of
FVC was 2.56 L, and the sensitivity and specificity were
86% and 48%, respectively. For FEV1, the optimal cut-off
value was 1.80 L, and the sensitivity and specificity were
88% and 50%, respectively. For PEF, the optimum cut-off
value was 3.40 L, and the sensitivity and specificity were
86% and 51%, respectively.
Discussion
In the present study, we explored the correlation between
respiratory parameters, physical performance, and
sarcopenia in a large and unselected sample of community-
dwelling subjects without known lung disease. Our findings
show that pulmonary function, assessed by FEV1, FVC, and
PEF, is linearly associated with low physical performance,
assessed by chair stand and handgrip strength tests. Further-
more, using the ROC analysis, the present results clearly
indicate that respiratory function significantly correlated to
Figure 2 The correlation between pulmonary function and handgrip test in male participants (Panels A, B, and C) and female participants (Panels D, E,
and F). FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEF, peak expiratory flow.
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the presence of probable sarcopenia, evaluated according to
the recent EWGSOP2 consensus.23
A number of studies have assessed the relationships of
respiratory function with muscle mass and muscle function
in patients with chronic obstructive pulmonary disease
(COPD).24–26 These previous studies were conducted in older
patients in hospitals and/or nursing homes, not in
community-dwelling subjects, and had mostly small sample
sizes. Nevertheless, few studies have explored lung function
in healthy subjects.25,27,28 Our survey is the first assessing
pulmonary and physical function in a general and in a large
sample of non-selected population. In this respect, the
Look-up 7+ project provided a unique opportunity to assess
this relationship among subjects of any age and gender
entered exhibition hall and/or shopping centre to visit stands
and not to do a lifestyle interview and a health evaluation.
This is the first largest study demonstrating that FVC, FEV1,
and PEF are positively associated with handgrip strength and
chair stand tests, and the positive association found between
them can be applied to apparently healthy community-
dwelling people. Specific mechanisms could elucidate the
significant relationships between pulmonary function and
physical performance. Respiratory muscle strength has a
significant role in the respiratory system, which regulates
the interaction between lung function and the respiratory
muscles to maintain sufficient ventilation.29 Independent of
specific pulmonary diseases, subjects with reduced lean body
mass may have weakened capacity to inflate and deflate their
lungs. Hence, the values of FVC, FEV1, and PEF can decline.
In this study, FVC, FEV1, and PEF appeared as important
parameters associated with the presence of probable
sarcopenia. Considering the recent EWGSOP2 consensus that
defines probable sarcopenia as low muscle strength and its
severity on physical performance, pulmonary function could
be considered in the sarcopenia screening and assessment
algorithm. For example, PEF is the maximum speed of
expiration, which is usually used to monitor patients with
obstructive lung diseases such as COPD and asthma. How-
ever, in healthy subjects without definite pulmonary diseases,
PEF correlates with the lung volume as well as the expiratory
muscle strength and power.28 In fact, some studies showed
that PEF values increased by specific expiratory muscle
strength training.29 Hence, our finding of FVC, FEV1, and
PEF related to physical performance and sarcopenia is sub-
stantially consistent with previous studies. These three pul-
monary parameters assessed by the AirSmart spirometer
system (https://www.nuvoair.com/) could represent a rapid
and convenient method for screening lung function in healthy
subjects and in subjects with probable sarcopenia.30 Hence,
measuring FVC, FEV1, and PEF could be useful for the screen-
ing of lung dysfunction in asymptomatic adults with de-
creased skeletal muscle performance.
Albeit dealing with a highly relevant issue, our study
presents several limitations that need to be discussed. First,
the results shown in this paper were obtained from a cross-
sectional survey limiting the ability to draw cause-and-effect
implications between different levels of FVC, FEV1, and
PEF with physical performance and sarcopenia. As a
Figure 3 Receiver operating characteristic curve analysis for predicting sarcopenia (by means of low handgrip strength) according to pulmonary func-
tion. The receiver operating characteristic curve analysis revealed that the areas under the curves for FVC, FEV1, and PEF were 0.788, 0.804, and 0.807,
respectively. FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEF, peak expiratory flow.
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consequence, the ability to recognize whether pulmonary
function is correlated with physical function and the onset
of sarcopenia over time is limited. A deeper understanding
of the correlation between pulmonary function and
sarcopenia requires the analysis of prospective data that are
not available at this stage for our study. Second, the type of
evaluation could influence the assessment of some health
metrics, pulmonary function, and physical performance. For
example, even though the pulmonary assessment and
physical performance were measured according to standard
protocols, people who decided to participate in the study
procedures were involved—before being assessed—in usual
activities, such as walking, carrying bags, and eating. The
activities, performed immediately before being evaluated,
could have influenced the assessment. Limitations also
include lack of information about conditions, such as asthma,
COPD, and other pulmonary disease that have a direct impact
on FVC, FEV1, and PEF. However, for the type of participants
recruited in the study, it is possible to exclude that acute
illnesses were present at the time of evaluation. Finally, the
population included only Caucasian persons, so our results
may not be applicable to other ethnic groups.
Apart from these limitations, this study offers a unique
opportunity to investigate the pulmonary function and
physical performance among an unselected population. The
results clearly show that pulmonary function was positively
associated with handgrip strength and chair stand tests. Given
the health implications of pulmonary function, timely detec-
tion of lower handgrip strength and impaired chair stand test
may be useful in assessment of potential pulmonary function
impairment.
In conclusion, based on this observation, muscle strength,
physical performance, and pulmonary function should be
recommended as the method of choice for the early detec-
tion of individuals at risk of probable sarcopenia and at the
same time to better characterize the severity of sarcopenia
status.27,31,32 Finally, despite extensive research efforts, the
mechanism responsible for the interaction between muscle
strength, muscle function, and pulmonary performance has
not been completely elucidated. A greater understanding of
the mechanisms that impair muscle quality may reveal
targets for intervention aimed at improving mobility and
preventing disability in late life.
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